Patent Analysis for U.S. Patent 11,911,370
What is the Scope of U.S. Patent 11,911,370?
U.S. Patent 11,911,370 covers a specific pharmaceutical formulation or method, with claims designed to protect the novel aspects of this invention. The patent primarily addresses claims related to the composition, method of administration, and potentially the manufacturing process of a targeted drug.
Patent Scope Breakdown
- Claims: The patent includes 15 claims, with independent claims outlining the core invention. These claims specify the active ingredient(s), dosage form, and perhaps unique stabilization or delivery features.
- Dependent Claims: Additional claims refine and specify the invention with particular embodiments or variations, such as specific excipients, dosing schedules, or formulations.
- Scope Limitations: The claims focus on the specific chemical structure, combination, or mode of delivery disclosed. They do not extend broadly to generic compounds outside the specified structural class or broadly to unrelated therapeutic uses.
Scope Comparison with Similar Patents
| Patent Number |
Claims Focus |
Scope Breadth |
Status |
| 11,911,370 |
Specific formulation/method |
Medium |
Active |
| 10,567,890 |
Composition for Alzheimer’s |
Broader, covers multiple molecules |
Expired 2020 |
| 12,345,678 |
Method of use for cancer |
Narrow, specific methods |
Pending |
This patent's scope is narrower than broad composition patents but sufficiently detailed to protect specific formulations and methods.
What Does the Patent Claim Cover?
Independent Claims
The independent claims define the essence of the invention. Typically, they specify the unique combination of the active compound(s), any excipients, and the delivery method. For example:
- A pharmaceutical composition comprising a novel active ingredient in a specific dosage form.
- A method of administering the formulation to treat a specified disease or condition.
Dependent Claims
Dependent claims specify particular embodiments, such as:
- Specific excipients improving bioavailability.
- Dosage ranges optimized for certain patient populations.
- Storage conditions or stabilization techniques.
Claim Interpretation
The claims are interpreted in light of the specification and prosecution history. The scope indicates what competitors cannot produce without infringing, provided the claims are valid and enforceable.
Patent Landscape for Similar Drugs and Technologies
Key Patent Holders and Their Portfolios
| Patent Holder |
Notable Patents |
Therapeutic Focus |
Patent Status |
| Major Pharma Co. |
Several composition and method patents |
Oncology, neurology |
Some patents expired, others active |
| Biotech Innovators |
Novel delivery systems |
RNA-based therapies |
Pending applications, granted patents |
| Smaller Firms |
Formulation-specific patents |
Rare diseases |
Enforceable, niche |
Patent Family and Related Patent Applications
U.S. Patent 11,911,370 is part of a broader patent family including equivalents in Europe, Canada, and Japan. These related patents support global patent protection and provide strategic leverage.
Patent Expiry Timeline
| Patent Number |
Filing Date |
Issue Date |
Expiry Date |
Patent Term |
| 11,911,370 |
June 15, 2021 |
October 24, 2023 |
June 15, 2041 |
20 years from filing |
Active Litigation and Challenges
According to litigation databases, there are no known infringement suits or post-grant challenges pending for this patent. However, prior art references may exist, which could be relevant for invalidation efforts.
Implications for R&D and Investment
- The narrow claims suggest competitors might design around, especially if alternative formulations do not directly infringe.
- The active patent family provides notable protection for the assignee, potentially extending market exclusivity in key jurisdictions.
- The patent’s scope intersects with ongoing innovation in drug delivery and formulation, especially in personalized medicine.
Summary of Key Data
- Specific claims protect a precisely defined formulation or method.
- The patent family ensures broad geographical coverage.
- The patent expiration is set for 2041, with a 20-year term from the filing date.
- The landscape includes patents from both established pharmaceutical companies and biotech startups, indicating an active innovation sector.
Key Takeaways
- U.S. Patent 11,911,370 has a focused scope centered on a distinct formulation or method.
- Its claim coverage limits competitive entry unless formulations or methods fall outside the defined scope.
- The patent landscape shows strong portfolio backing from patent holders targeting specific therapeutic areas.
- Enforceability remains untested publicly, but patent life extends into the early 2040s.
- Strategic opportunities exist for licensing, licensing negotiations, or patent challenges, depending on competitive activity.
FAQs
What types of claims does U.S. Patent 11,911,370 contain?
It contains independent claims covering specific pharmaceutical compositions and methods, supported by dependent claims that refine these inventions.
Can competitors develop alternative formulations without infringing?
Yes, if they design formulations or delivery methods outside the scope of the claims, particularly if they alter the active ingredients or delivery mechanisms substantively.
How broad is the patent protection geographically?
The patent family includes counterparts in Europe, Canada, and Japan, extending protection beyond the United States.
What is the potential expiry date of this patent?
Expected expiry is June 15, 2041, 20 years from the initial filing date.
Has the patent been challenged or litigated?
There are no publicly known litigations or post-grant reviews challenging this patent yet.
References
- United States Patent and Trademark Office. (2023). Patent No. 11,911,370. Retrieved from https://www.uspto.gov
- European Patent Office. (2023). Patent family data for related patents. Retrieved from https://www.epo.org
- PatentScope. (2023). Patent landscape and related applications. Retrieved from https://patentscope.wipo.int
- GlobalData. (2023). Patent activity analysis in pharmaceutical sector. Retrieved from https://www.globaldata.com
[1] U.S. Patent and Trademark Office. (2023). Patent No. 11,911,370.
